Voices of Epilepsy interviewed epilepsy researchers this past spring to get their response to Phase II clinical trial results from an open-label study of cannabdiol in treatment resistant epilepsy. The data was presented at the 2015 American Academy of Neurology annual meeting.
May 1, 2015 CBD study shows promise, but more trials needed
For additional background, see the following press release from the American Academy of Neurology: Medical Marijuana Liquid Extract May Bring Hope for Children with Severe Epilepsy
In June, following a ruling from the Supreme Court that expanded the definition of medical marijuana beyond the dried form, Voices of Epilepsy interviewed parents who have children with refractory epilepsy.